Dr. Lestter Cruz Serrano is the Head of Global Medical Affairs & Health Sciences Strategy in Cognizant, responsible for all 3 verticals – Healthcare, Life Sciences & Medical Devices – under the Cognizant Health Sciences division. His role involves spearheading Cognizant’s efforts in shaping the medical strategy for the Health Sciences division.
He has been instrumental in driving adoption of Cognizant’s products & platforms, like, Shared Investigator Platform (SIP)—the industry’s first collaborative SaaS clinical ecosystem—across prestigious clinical research Sites worldwide and in the process, actively collaborating & forging relationship with global pharmaceutical companies who’ve adopted SIP.
Prior to this role, Dr. Cruz worked at CHI Health, where he led the Hematology and Oncology studies for the NIH Cooperative Group and Pharmaceutical Trials. He has also worked at Nebraska Medicine & the University of Nebraska Medical Center where he conducted phase II & III clinical trials for Diabetic, Endocrinology, Metabolic and Cardiovascular patients. He received his M.D. degree from the UAG School of Medicine and trained as a Family physician. He is a Board-Certified Medical Affairs Specialist and currently is working on his MBA.